Agents required to screen blood products.
Ended Awarded Last action
- Contract number
- HT009026FH003
- Awardee
-
Phadia US Inc. UEI DK4EVCWUNUM4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $49,923
Award facts
- Contract value 100% obligated
- $49,923.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portage, MI 49002, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a BPA call to Phadia US Inc. on May 6, 2026, for agents required to screen blood products, with a ceiling value of $49,923.06. Work is performed in Portage, Michigan, with an ultimate completion date of September 30, 2026. The call is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract HT009026FH003?
HT009026FH003 was awarded to Phadia US Inc. by Defense Health Agency (Department of Defense) on May 6, 2026.
How much is contract HT009026FH003 worth?
The government has obligated $49,923 on HT009026FH003.
Is contract HT009026FH003 an order under another contract?
Yes. HT009026FH003 is a BPA call under FA301624A0046, a blanket purchase agreement.
Was contract HT009026FH003 competed?
The extent of competition for HT009026FH003 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award